Nasal Gel for Low Testosterone Gets FDA Approval
Trimel Pharmaceuticals Corporation (TSX: TRL) announced today that the United States Food and Drug Administration (FDA) has approved Natesto™ (testosterone), formerly CompleoTRT™, to treat men with low testosterone.